Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 26, 2021

SELL
$181.39 - $202.99 $358,426 - $401,108
-1,976 Closed
0 $0
Q2 2021

Jul 22, 2021

SELL
$187.49 - $221.1 $4.17 Million - $4.91 Million
-22,226 Reduced 91.84%
1,976 $398,000
Q1 2021

Apr 12, 2021

BUY
$207.02 - $241.31 $90,881 - $105,935
439 Added 1.85%
24,202 $5.2 Million
Q4 2020

Jan 27, 2021

BUY
$207.01 - $276.09 $235,370 - $313,914
1,137 Added 5.03%
23,763 $5.62 Million
Q3 2020

Oct 26, 2020

SELL
$255.65 - $303.1 $144,442 - $171,251
-565 Reduced 2.44%
22,626 $6.16 Million
Q2 2020

Jul 27, 2020

BUY
$225.48 - $295.8 $145,209 - $190,495
644 Added 2.86%
23,191 $6.73 Million
Q1 2020

Apr 28, 2020

BUY
$199.77 - $247.81 $4.5 Million - $5.59 Million
22,547 New
22,547 $5.37 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Calamos Wealth Management LLC Portfolio

Follow Calamos Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Wealth Management LLC with notifications on news.